
News|Articles|November 12, 2024
Patient Perspectives on Colonoscopies: Daily Dose
Author(s)Sydney Jennings
Your daily dose of the clinical news you may have missed.
Advertisement
Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
On October 25, 2024, we reported on findings of a recent survey that highlighted patient perspectives on colonoscopies and barriers that prevent them from undergoing the procedure.
The study
The survey included 506 US adults aged 45 years and older, of whom 302 had a colonoscopy in the past 5 years and 204 who did not. The survey was conducted online from December 7-15, 2023, by The Harris Poll on behalf of Salix Pharmaceuticals. Survey participants were selected from among individuals who agreed to participate in The Harris Poll surveys.
The findings
58% of the respondents who previously had a colonoscopy report wishing they knew more information before their first procedure, including prep medication options and how to prepare for the procedure.
78% of all participants said they rely on their health care provider for more information about colonoscopies and the preparation process.
73% of the cohort said their physician recommended they receive a colonoscopy; however, only 34% of all participants said their physician discussed the different prep medication options with them.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Provider Specialty and Type Drive Divergent Prescribing Patterns for Symptoms of Menopause
2
New Large-Scale Study Challenges Previous Research on Menopause and Brain Structure
3
Orforglipron Achieves Up to 12% Weight Loss in Obesity Phase 3 Study: Daily Dose
4
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks
5